Preview Mode Links will not work in preview mode

Jul 10, 2019

On Episode 76 of the podcast, I spoke with Kristen Kneff from ImmunsanT about the presentation she gave at The State of Celiac event held in May by the Canadian Celiac Association.  Kristen’s presentation, and our subsequent interview looked at the Phase 2 trial for Nexvax2, a vaccine to minimize the effects of gluten on those with celiac disease.  Recently, the trial was halted, as the vaccine was not performing as expected.

Ellen Bayens of brought this to my attention in an article looking at both the press release from ImmunsanT and a position piece from Dr. Peter Green.  On this episode of the podcast, Ellen and I speak about what this news means for the research community as well as the impact on the celiac community.

You can read the article at the following link –


Sue’s Websites and Social Media


Podcast Blog –

Facebook - @acanadianceliacpodcast

Twitter – CeliacPodcastCA

Email –

Baking Website –

Instagram - @suesgfbaking

YouTube -

     (search Sues Gluten Free Baking)

Email –

Other Podcast – Gluten Free Weigh In –